| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 9 | 0 | 0 | 9 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
| Carbonic anhydrase 1 | 0 | 4 | 0 | 7 |
| Carbonic anhydrase 2 | 0 | 4 | 0 | 8 |
| Alanine racemase, biosynthetic | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 4 | 1 | 6 |
| Proton-coupled amino acid transporter 1 | 0 | 3 | 0 | 3 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 2 |
| glp-1 receptor, partial | 6 | 0 | 0 | 6 |
| thioredoxin reductase | 19 | 0 | 0 | 19 |
| GLS protein | 11 | 0 | 0 | 11 |
| regulator of G-protein signaling 4 | 9 | 0 | 0 | 9 |
| estrogen-related nuclear receptor alpha | 17 | 0 | 0 | 17 |
| estrogen nuclear receptor alpha | 21 | 0 | 0 | 21 |
| NPYLR7B | 0 | 0 | 2 | 2 |
| arylsulfatase A | 7 | 0 | 0 | 7 |
| euchromatic histone-lysine N-methyltransferase 2 | 17 | 0 | 0 | 17 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 | 7 | 0 | 0 | 7 |
| ATP-binding cassette sub-family C member 3 | 0 | 15 | 0 | 15 |
| Multidrug resistance-associated protein 4 | 0 | 15 | 0 | 15 |
| Bile salt export pump | 0 | 24 | 0 | 24 |
| Beta-2 adrenergic receptor | 0 | 7 | 6 | 14 |
| Beta-1 adrenergic receptor | 0 | 5 | 5 | 10 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| 60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 4 | 4 | 8 |
| Delta-type opioid receptor | 0 | 2 | 2 | 5 |
| 10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 1 | 2 | 5 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| 10 kDa chaperonin | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 3 | 5 | 10 |
| Canalicular multispecific organic anion transporter 1 | 0 | 15 | 0 | 15 |
| ATP-dependent phosphofructokinase | 10 | 0 | 0 | 10 |
| USP1 protein, partial | 6 | 0 | 0 | 6 |
| Microtubule-associated protein tau | 11 | 0 | 0 | 11 |
| lamin isoform A-delta10 | 17 | 0 | 0 | 17 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
| histone acetyltransferase KAT2A isoform 1 | 6 | 0 | 0 | 6 |
| Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
| Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
| Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
| Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-1 angiotensin II receptor | 0 | 3 | 3 | 6 |
| Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
| ATAD5 protein, partial | 5 | 0 | 0 | 5 |
| TDP1 protein | 20 | 0 | 0 | 20 |
| Bloom syndrome protein isoform 1 | 7 | 0 | 0 | 7 |
| D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
| neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
| Atrial natriuretic peptide receptor 1 | 0 | 1 | 1 | 2 |
| Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
| pregnane X receptor | 3 | 0 | 0 | 3 |
| GLI family zinc finger 3 | 15 | 0 | 0 | 15 |
| AR protein | 21 | 0 | 0 | 21 |
| progesterone receptor | 9 | 0 | 0 | 9 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 11 | 0 | 0 | 11 |
| glucocorticoid receptor [Homo sapiens] | 12 | 0 | 0 | 12 |
| farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
| pregnane X nuclear receptor | 14 | 0 | 0 | 14 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 11 | 0 | 0 | 11 |
| IDH1 | 8 | 0 | 0 | 8 |
| aryl hydrocarbon receptor | 6 | 0 | 0 | 6 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 11 | 0 | 0 | 11 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 7 | 0 | 0 | 7 |
| galanin receptor type 3 | 0 | 2 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 14 | 0 | 0 | 14 |
| Voltage-dependent calcium channel gamma-2 subunit | 7 | 0 | 0 | 7 |
| Glucocorticoid receptor | 0 | 10 | 2 | 17 |
| Glycine receptor subunit alpha-1 | 0 | 10 | 0 | 10 |
| Glutamate receptor 2 | 7 | 0 | 0 | 7 |
| Glycine receptor subunit beta | 0 | 10 | 0 | 10 |
| Glycine receptor subunit alpha-2 | 0 | 10 | 0 | 10 |
| Glycine receptor subunit alpha-3 | 0 | 10 | 0 | 10 |
| ORF73 | 0 | 0 | 1 | 1 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 8 | 0 | 0 | 8 |
| Thrombopoietin | 3 | 0 | 0 | 3 |
| thioredoxin glutathione reductase | 7 | 0 | 0 | 7 |
| Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 2 |
| peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
| chromobox protein homolog 1 | 11 | 0 | 0 | 11 |
| M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Renin | 0 | 2 | 0 | 2 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Leukotriene A-4 hydrolase | 0 | 2 | 1 | 3 |
| EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 3 | 1 | 4 |
| Angiotensin-converting enzyme | 0 | 4 | 0 | 5 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Thymidine phosphorylase | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
| Succinyl-diaminopimelate desuccinylase | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase TEM | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 1 | 3 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 2 | 0 | 3 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 0 | 1 |
| Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 2 |
| Chain A, Beta-lactamase | 9 | 0 | 0 | 9 |
| acetylcholinesterase | 3 | 0 | 0 | 3 |
| GALC protein | 5 | 0 | 0 | 5 |
| peroxisome proliferator activated receptor gamma | 6 | 0 | 0 | 6 |
| thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 9 | 0 | 0 | 9 |
| geminin | 14 | 0 | 0 | 14 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 3 | 8 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 2 | 6 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 2 | 7 |
| Muscarinic acetylcholine receptor M3 | 0 | 3 | 2 | 6 |
| Muscarinic acetylcholine receptor M4 | 0 | 3 | 1 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 3 | 1 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 2 | 6 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 1 | 5 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 3 | 8 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 2 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 3 | 3 | 8 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 4 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 2 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 5 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
| Luciferase | 4 | 0 | 0 | 4 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| RAR-related orphan receptor gamma | 14 | 0 | 0 | 14 |
| NFKB1 protein, partial | 6 | 0 | 0 | 6 |
| caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
| aldehyde dehydrogenase 1 family, member A1 | 11 | 0 | 0 | 11 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 8 | 0 | 0 | 8 |
| thyroid stimulating hormone receptor | 10 | 0 | 0 | 10 |
| nuclear receptor subfamily 1, group I, member 3 | 9 | 0 | 0 | 9 |
| EWS/FLI fusion protein | 7 | 0 | 0 | 7 |
| retinoic acid nuclear receptor alpha variant 1 | 10 | 0 | 0 | 10 |
| bromodomain adjacent to zinc finger domain 2B | 5 | 0 | 0 | 5 |
| peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
| caspase-3 | 3 | 0 | 0 | 3 |
| activating transcription factor 6 | 5 | 0 | 0 | 5 |
| Histone H2A.x | 5 | 0 | 0 | 5 |
| vitamin D3 receptor isoform VDRA | 7 | 0 | 0 | 7 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform 2 | 13 | 0 | 0 | 13 |
| FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 5 | 0 | 0 | 5 |
| plasminogen precursor | 5 | 0 | 0 | 5 |
| urokinase plasminogen activator surface receptor precursor | 5 | 0 | 0 | 5 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| muscleblind-like protein 1 isoform 1 | 5 | 0 | 0 | 5 |
| muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 4 |
| Cellular tumor antigen p53 | 8 | 0 | 0 | 8 |
| Cytochrome P450 2D6 | 0 | 5 | 0 | 5 |
| Nuclear receptor ROR-gamma | 6 | 1 | 1 | 8 |
| Spike glycoprotein | 8 | 0 | 0 | 8 |
| Carbonic anhydrase 9 | 0 | 2 | 0 | 4 |
| ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
| Ataxin-2 | 8 | 0 | 0 | 8 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
| retinoid X nuclear receptor alpha | 8 | 0 | 0 | 8 |
| cytochrome P450 2D6 | 6 | 0 | 0 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 1 | 7 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 8 | 1 | 10 |
| 5-hydroxytryptamine receptor 1A | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 4 | 4 | 9 |
| D(2) dopamine receptor | 0 | 4 | 1 | 5 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 7 | 1 | 8 |
| Alpha-2B adrenergic receptor | 0 | 3 | 1 | 5 |
| Alpha-2C adrenergic receptor | 0 | 4 | 3 | 8 |
| D | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 4 | 1 | 6 |
| Alpha-2B adrenergic receptor | 0 | 5 | 1 | 6 |
| D(1A) dopamine receptor | 0 | 3 | 1 | 4 |
| Alpha-2C adrenergic receptor | 0 | 5 | 1 | 6 |
| Alpha-2A adrenergic receptor | 0 | 5 | 1 | 6 |
| Alpha-1D adrenergic receptor | 0 | 5 | 1 | 6 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 2 | 6 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 2C | 0 | 6 | 1 | 7 |
| 5-hydroxytryptamine receptor 1B | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 2 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1F | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 1 | 3 |
| Alpha-1A adrenergic receptor | 0 | 3 | 4 | 9 |
| Alpha-1B adrenergic receptor | 0 | 2 | 3 | 7 |
| D(3) dopamine receptor | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 1 | 5 |
| Alpha-1A adrenergic receptor | 0 | 7 | 1 | 8 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 5 | 0 | 5 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 9 | 0 | 9 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 5 | 0 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 7 | 0 | 8 |
| Sodium channel protein type 5 subunit alpha | 0 | 6 | 0 | 6 |
| Neutral alpha-glucosidase AB | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 2 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
| Heparanase | 0 | 0 | 1 | 1 |
| Alkaline phosphatase, germ cell type | 0 | 1 | 0 | 1 |
| G protein-coupled receptor GPR35 | 0 | 0 | 1 | 1 |
| G-protein coupled receptor 35 | 0 | 0 | 1 | 1 |
| G-protein coupled receptor 35 | 0 | 1 | 2 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| PAX8 | 0 | 0 | 0 | 1 |
| SMAD family member 2 | 5 | 0 | 0 | 5 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| SMAD family member 3 | 5 | 0 | 0 | 5 |
| STAT3, partial | 0 | 1 | 0 | 1 |
| Smad3 | 6 | 0 | 0 | 6 |
| estrogen receptor 2 (ER beta) | 5 | 0 | 0 | 5 |
| 67.9K protein | 4 | 0 | 0 | 4 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| tumor necrosis factor | 2 | 0 | 0 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 4 | 0 | 0 | 4 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 5 | 0 | 0 | 5 |
| lethal factor (plasmid) | 7 | 0 | 0 | 7 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 3 |
| Interferon beta | 6 | 0 | 0 | 6 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 2 | 0 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 8 | 0 | 10 |
| Integrin alpha-IIb | 2 | 0 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit pi | 6 | 1 | 1 | 8 |
| Solute carrier family 22 member 1 | 0 | 8 | 0 | 13 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
| Cytochrome P450 2C9 | 0 | 7 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 1 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit delta | 6 | 1 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 1 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 1 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 1 | 1 | 8 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 1 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 1 | 1 | 8 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 1 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 1 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 1 | 1 | 8 |
| Sodium channel protein type 1 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 3 |
| Histamine H2 receptor | 4 | 0 | 2 | 6 |
| 5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 5 |
| Cytochrome P450 2J2 | 0 | 6 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 1 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 1 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 1 | 1 | 8 |
| Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 3 | 0 | 3 |
| Sodium channel protein type 9 subunit alpha | 0 | 3 | 0 | 3 |
| GABA theta subunit | 6 | 1 | 1 | 8 |
| Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | 6 | 1 | 1 | 8 |
| Sodium channel protein type 3 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium channel protein type 11 subunit alpha | 0 | 2 | 0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 3 |
| Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
| Chain A, GLUTATHIONE TRANSFERASE A1-1 | 0 | 1 | 0 | 1 |
| Chain A, Glutathione S-transferase P1-1 | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
| Chain A, Glutathione S-transferase P1-1 | 0 | 1 | 0 | 1 |
| Chain B, Glutathione S-transferase P1-1 | 0 | 1 | 0 | 1 |
| Nrf2 | 1 | 0 | 0 | 1 |
| WRN | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| G | 3 | 0 | 0 | 3 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3 | 0 | 0 | 3 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
| perilipin-5 | 0 | 2 | 0 | 2 |
| perilipin-1 | 0 | 2 | 0 | 2 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 2 | 0 | 2 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| Hematopoietic prostaglandin D synthase | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
| Glutathione S-transferase A1 | 0 | 1 | 0 | 1 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1a | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 2 | 0 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 6 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
| UDP-glucose 4-epimerase | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
| 14 kDa phosphohistidine phosphatase | 0 | 2 | 0 | 2 |
| cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
| large T antigen | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 5 | 0 | 5 |
| Albumin | 0 | 2 | 1 | 3 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 4 |
| Carbonic anhydrase 6 | 0 | 2 | 0 | 4 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 3 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 3 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 3 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
| aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 4 |
| Solute carrier family 22 member 3 | 0 | 3 | 0 | 4 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
| Histamine H2 receptor | 0 | 1 | 2 | 3 |
| Adenosine receptor A1 | 0 | 2 | 0 | 4 |
| Adenosine receptor A2a | 0 | 2 | 0 | 5 |
| Histamine H1 receptor | 0 | 1 | 3 | 4 |
| Histamine H1 receptor | 0 | 2 | 1 | 3 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
| Histamine H1 receptor | 0 | 2 | 2 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 4 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 4 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 5 |
| Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 4 |
| Solute carrier family 22 member 1 | 0 | 5 | 0 | 9 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 4 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 5 | 0 | 7 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 4 |
| Histamine H3 receptor | 0 | 1 | 2 | 3 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| Fumarate hydratase | 2 | 0 | 0 | 2 |
| hypothetical protein, conserved | 3 | 0 | 0 | 3 |
| polyprotein | 2 | 0 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 2 | 5 |
| beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| Beta-2 adrenergic receptor | 0 | 4 | 1 | 6 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
| Beta-1 adrenergic receptor | 0 | 5 | 2 | 9 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 3 | 1 | 4 |
| Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 2 | 0 | 0 | 2 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 1 | 2 | 3 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 3 | 0 | 3 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 2 | 0 | 2 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 2 | 0 | 0 | 2 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| dopamine D1 receptor | 2 | 0 | 0 | 2 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
| Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 0 | 1 | 1 |
| Histidine decarboxylase | 0 | 0 | 1 | 1 |
| Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 5 |
| Mu-type opioid receptor | 0 | 2 | 1 | 6 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
| Mu-type opioid receptor | 0 | 3 | 2 | 6 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 3 | 2 | 6 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 3 | 2 | 6 |
| Mu-type opioid receptor | 0 | 2 | 1 | 6 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 4 | 1 | 5 |
| Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 4 | 3 | 8 |
| Adenosine receptor A1 | 0 | 4 | 1 | 7 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
| Leukotriene B4 receptor 1 | 0 | 0 | 0 | 1 |
| Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 2 | 0 | 0 | 0 | 1 |
| Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
| Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 2 |
| Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| Glutamate 5-kinase | 0 | 0 | 0 | 1 |
| Neutral amino acid transporter A | 0 | 2 | 0 | 2 |
| Neutral amino acid transporter B(0) | 0 | 2 | 0 | 2 |
| Amino acid transporter | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Endothelin-1 receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 1 | 3 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
| Multidrug resistance protein 1a | 0 | 0 | 0 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 4 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 4 | 0 | 0 | 0 | 1 |
| Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
| Chitotriosidase-1 | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 0 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
| Endochitinase B1 | 0 | 1 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Chain A, ykoF | 0 | 0 | 1 | 1 |
| Chain B, ykoF | 0 | 0 | 1 | 1 |
| Chain A, ThiT | 0 | 0 | 1 | 1 |
| Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
| Transketolase | 0 | 0 | 1 | 1 |
| Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |